BDPT OTC
BioAdaptives Inc.
1W: -58.3%
1M: +87.8%
3M: +53.9%
YTD: -90.9%
1Y: -96.9%
3Y: -96.2%
5Y: -99.9%
$0.00
+0.00 (+5.00%)
Weekly Expected Move ±47.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$13K
-55.6% ▼
5Y CAGR: +5.0%
Gross Profit
$4K
-62.8% ▼
5Y CAGR: -3.8%
Operating Income
-$602K
-162.9% ▼
Net Income
-$899K
-26.3% ▼
EPS (Diluted)
$-0.11
+8.3% ▲
EBITDA
-$582K
-11.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $16K | $20K | $17K | $29K | $13K |
| YoY Growth | +64.4% | +21.1% | -13.1% | +66.3% | -55.6% |
| Cost of Revenue | $10K | $10K | $10K | $18K | $9K |
| Gross Profit | $6K | $10K | $7K | $11K | $4K |
| Gross Margin | 37.3% | 51.1% | 41.5% | 37.9% | 31.8% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $260K | $512K | $367K | $212K | $505K |
| Operating Expenses | $260K | $637K | $429K | $240K | $606K |
| Operating Income | -$254K | -$636K | -$422K | -$229K | -$602K |
| Operating Margin | -1555.7% | -3216.0% | -2456.9% | -801.7% | -4751.8% |
| Interest Expense | $230K | $272K | $289K | $163K | $92K |
| Income Before Tax | -$847K | -$1M | -$896K | -$712K | -$905K |
| Tax Expense | $0 | $0 | $0 | $0 | -$6K |
| Net Income | -$847K | -$1M | -$896K | -$712K | -$899K |
| Net Margin | -5187.7% | -5309.5% | -5216.6% | -2492.6% | -7096.1% |
| EPS (Diluted) | $-6.23 | $-4.67 | $-1.27 | $-0.12 | $-0.11 |
| EBITDA | -$363K | -$644K | -$544K | -$521K | -$582K |
| Shares Outstanding | 135917 | 224951 | 706736 | 6M | 8M |